NASDAQ: NRC - National Research Corporation

Yield per half year: -41.6%
Dividend yield: +2.06%
Sector: Healthcare

National Research Corporation

42.0042.0035.0035.0028.0028.0021.0021.0014.0014.007.007.00Apr '24Apr '24May '24May '24Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
5/10
31.79 57.09 -44.31% 34.39 -7.55%
P/S 6.63 33.5 -80.21%
P/BV 20.11 4.61 335.93%
P/FCF 0 39.66 -100%
Ev/Ebitda 22.12 -19.46 -213.67%
Ev/S 6.84 22.56 -69.66%
Ev/FCF 45.54 45.47 0.1451%
E/P 0 0.0172 -100%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
9/10
30.95 -14.42 -314.62% 34.42 -10.08%
ROE 63.26 9.01 602.12%
ROA 25.3 0.0151 166924.75%
ROIC 0 7.63 -100%
ROS 20.84 -26.5 -178.63%
ROCE 81.88 13.75 495.36%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
9/10
0.8109 -3.73 -121.75% 0.6731 +20.47%
Nеt Debt/Ebitda 0.7025 -3.19 -122%
Debt/Ratio 0.3045 0.1777 71.36%
Debt/Equity 2.17 1.57 37.94%
Debt/Net Income 1.2 0.8429 42.83%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
5.15/10
2.06 0.5467 276.83% 1.61 +28.17%
Number of years of dividend growth 3 0.7368 307.14%
DSI 0.8571 0.2387 259.06%
Average dividend growth -19.99 1.55 -1393.94%
Average percentage for 5 years 1.61 0.4967 223.57%
Average percentage for payments 70.19 43.73 60.5%
Difference from average difference in sector 1.51

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
3/10
16.08 73.67 -78.17%
Growth impulse Ebitda in 5 years -4.4 15.28 -128.8%
Growth impulse Net Income in 5 years -4.41 -33.08 -86.67%
Growth impulse FCF in 5 years -38.47 -6.99 450.36%
Growth impulse EPS in 5 years -0.3763 -59.11 -99.36%
IP Score
5.22/10

Similar companies

Alexion

Amgen

ABIOMED

Gilead Sciences

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription